A patient living with diabetes who is also trying to quit smoking might reasonably choose a GLP-1 drug over another glucose-lowering medication, not because it is approved for smoking cessation, but because it may help them quit, a benefit that other diabetes drugs do not offer. Similarly, for people living with obesity who also struggle with alcohol, the potential for benefit beyond weight loss could be one more reason to consider a GLP-1 drug.
TransformerLens
。PDF资料是该领域的重要参考
Scientists are also concerned that this announcement is a politically-motivated move in the new international race to the Moon.
文 | 智械岛，作者 | 霍如筠（北京）